Philip Morris International Inc (PM)
PM trades on NYSE in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$199.29
-1.34% on the day
Market cap
$310.6B
Mega cap
Revenue · 2025
$40.6B
+7.3% on 2024
Net income · 2025
$11.3B
27.9% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | PM on NYSE |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001413329 |
| SEC industry code | Cigarettes |
| Incorporated in | VA |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $40.6B |
| Net income | $11.3B |
| Operating income | $14.9B |
| Net margin | 27.9% |
| Operating margin | 36.6% |
| Revenue growth | +7.3% |
| Cash | $4.9B |
| Total assets | $69.2B |
| P/E (computed) | 27.4× |
| P/S (computed) | 7.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B2 | 2026-04-28 |
| Latest annual report | 10-K | 2026-02-06 |
| Latest quarterly / interim | 10-Q | 2026-07-24 |
| Latest current report | 8-K | 2026-09-18 |
| Latest proxy | DEFA14A | 2026-03-31 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +6.3% |
| 1 month | +5.5% |
| 3 months | +7.9% |
| Year to date | +27.7% |
| 1 year | +28.4% |
| From 52-week high | 0.0% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BTI | British American Tobacco Industries p.l.c. Common Stock ADR | $55.65 | +0.05% | $120.2B |
| MO | Altria Group Inc. | $71.56 | -0.14% | $119.5B |
| DFTX | Definium Therapeutics Inc. Common Shares | $34.38 | -2.33% | $4.6B |
| RGC | Regencell Bioscience Holdings Limited | $8.19 | +14.87% | $4.1B |
| RLX | RLX Technology Inc. | $1.71 | -0.58% | $2.1B |
| TRLV | Trulieve Cannabis Corp. Subordinate Voting Shares | $10.11 | -2.69% | $1.9B |
| CRON | Cronos Group Inc. Common Share | $3.20 | -0.31% | $1.2B |
| TLRY | Tilray Brands Inc. Common Stock | $3.27 | -2.68% | $483.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier